The estimated Net Worth of Capital Partners Gp, Llc Av... is at least $181 Millón dollars as of 14 August 2017. Capital Av owns over 140,846 units of Lantheus Inc stock worth over $12,488,059 and over the last 8 years Capital sold LNTH stock worth over $168,842,410.
Capital has made over 6 trades of the Lantheus Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Capital sold 140,846 units of LNTH stock worth $2,432,410 on 14 August 2017.
The largest trade Capital's ever made was selling 3,000,000 units of Lantheus Inc stock on 20 June 2017 worth over $44,610,000. On average, Capital trades about 2,356,808 units every 44 days since 2016. As of 14 August 2017 Capital still owns at least 122,492 units of Lantheus Inc stock.
You can see the complete history of Capital Av stock trades at the bottom of the page.
Over the last 9 years, insiders at Lantheus Inc have traded over $500,725,766 worth of Lantheus Inc stock and bought 8,000 units worth $141,200 . The most active insiders traders include David F Burgstahler, Capital Partners Gp, Llc Av... y Sriram Venkataraman. On average, Lantheus Inc executives and independent directors trade stock every 11 days with the average trade being worth of $15,777,680. The most recent stock trade was executed by James H Thrall on 21 August 2024, trading 1,000 units of LNTH stock currently worth $98,520.
lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.
Lantheus Inc executives and other stock owners filed with the SEC include: